Clinical Trial Update: Registry of Asthma Patients Initiating DUPIXENT®

View source ↗

Summary

This registry tracks asthma patients initiating DUPIXENT (dupilumab). The study is sponsored by Regeneron Pharmaceuticals and is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Asthma | Status: ACTIVE_NOT_RECRUITING